We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

35 hedge funds and large institutions have $66M invested in BioAmber Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

38,350% more call options, than puts

Call options by funds: $769K | Put options by funds: $2K

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

14% more capital invested

Capital invested by funds: $58.1M → $66M (+$7.85M)

3% more funds holding

Funds holding: 3435 (+1)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
10
Closed
3
Calls
$769K
Puts
$2K
Net Calls
+$767K
Net Calls Change
+$158K

BIOA Hedge Fund Activity: Q4 2015 in Review

35 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q4 2015, worth a combined $66M — up 14% from $58.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIOA positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $631K. The largest seller was Royce & Associates, cutting an estimated $747K.

  • 35 institutional investors held BioAmber Inc. (BIOA) as of Q4 2015, up from 34 in Q3 2015.
  • Funds reported $66M of BioAmber Inc. stock for Q4 2015, up 14% quarter-over-quarter.
  • 4 funds opened new BioAmber Inc. positions in Q4 2015 and 3 closed out, a net change of +1 holder.
  • The largest BioAmber Inc. buyer in Q4 2015 was Levin Capital Strategies, an estimated $631K added.
  • The largest BioAmber Inc. seller in Q4 2015 was Royce & Associates, an estimated $747K sold.

Based on aggregated 13F filings for Q4 2015.